Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein
Zeyan Pan(Second Military Medical University), Zonghai Li(Guizhou Normal University), Zhimin Shi(Qilu University of Technology), Yi Wang(Renji Hospital), Ying Liu(Renji Hospital), Hua Jiang(State Key Laboratory of Oncogene and Related Genes), Xiuqi Wu(Shanghai Jiao Tong University), Bizhi Shi(Shanghai Jiao Tong University), Min Yu(University of Maryland, Baltimore), Shengmeng Di(Shanghai Jiao Tong University), Hong Luo(Anshan Hospital)
Cited by 63
Related Papers
Mutations in <i>TUBB8</i> and Human Oocyte Meiotic Arrest
|New England Journal of Medicine|2016|324
Mutations in PADI6 Cause Female Infertility Characterized by Early Embryonic Arrest
|The American Journal of Human Genetics|2016|250
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
|Molecular Therapy|2017|184
Mutations in <i>TUBB8</i> cause a multiplicity of phenotypes in human oocytes and early embryos
|Journal of Medical Genetics|2016|164
Biallelic Mutations in PATL2 Cause Female Infertility Characterized by Oocyte Maturation Arrest
|The American Journal of Human Genetics|2017|163